Browse Title Index
Issue Title
Vol 48, No 5 (2014) Risk factors for re-bleeding of aneurysmal subarachnoid hemorrhage: Meta-analysis of observational studies Abstract   PDF
Gobran Taha Ahmed Alfotih, FangCheng Li, XinKe Xu, ShangYi Zhang
Vol 57, No 4 (2023) Risk factors for reoperation after surgical treatment for degenerative spinal disease in Poland: a nationwide retrospective study of 38,953 hospitalisations Abstract
Jerzy Słowiński, Michał Żurek, Agata Wypych-Ślusarska, Karolina Krupa-Kotara, Klaudia Oleksiuk, Joanna Głogowska-Ligus, Anna Kozioł, Milena Kozioł-Rostkowska
Vol 53, No 4 (2019) Risk factors predicting a higher grade of subarachnoid haemorrhage in small ruptured intracranial aneurysm ( < 5 mm) Abstract   PDF
Junli Tai, Jianxin Liu, Jianhua Lv, Kang Huibin, Zhe Hou, Jun Yang, Hongbing Zhang, Qing Huang
Vol 56, No 6 (2022) Role of DTI-MRI parameters in diagnosis of ALS: useful biomarkers for daily practice? Tertiary centre experience and literature review Abstract
Edyta Maj, Miłosz Jamroży, Maksymilian Bielecki, Marta Bartoszek, Marek Gołębiowski, Mikołaj Wojtaszek, Magdalena Kuźma-Kozakiewicz
Vol 54, No 5 (2020) Role of gadolinium-based contrast agents in neurological disorders Abstract   PDF
Weronika Golec, Aleksandra Jakimów-Kostrzewa, Bartosz Mruk, Sergiusz Jóźwiak
Vol 57, No 4 (2023) Role of orexin in pathogenesis of neurodegenerative parkinsonisms Abstract
Piotr Alster, Natalia Madetko-Alster, Dagmara Otto-Ślusarczyk, Anna Migda, Bartosz Migda, Marta Struga, Andrzej Friedman
Vol 55, No 1 (2021) Ruptured temporal horn aneurysm associated with Moyamoya collateral vessel coexisting with contralateral arteriovenous malformation — technical note with clinical vignette Abstract   PDF
Alejandro Feria, Grzegorz Brzezicki
Online first Saccades in Huntington’s Disease Details
Daniel Zielonka
Vol 55, No 2 (2021) Safety and efficacy of Botulinum toxin type A preparations in cerebral palsy — an evidence-based review Abstract   PDF
Marcin Bonikowski, Jarosław Sławek
Vol 54, No 4 (2020) Safety and tolerability of therapeutic plasma exchange in autoimmune neurological diseases — a retrospective single-centre analysis Abstract   PDF
Agnieszka Gala-Błądzińska, Katarzyna Mazur, Adam Dębiec, Krzysztof Gargasz, Halina Bartosik-Psujek
Online first Safety, efficacy and steroid-sparing effect of amifampridine in Lambert-Eaton myasthenic syndrome patients — real world data Abstract
Piotr Szczudlik, Ewa Sobieszczuk, Mieczysław Walczak, Anna Kostera-Pruszczyk
Vol 57, No 1 (2023) SARS-CoV-2 and the nervous system Details
Alina Kułakowska
Vol 57, No 2 (2023) SARS-CoV-2 infection complicated by neuro- or psycho-COVID Details   PDF   HTML
Sounira Mehri, ArunSundar MohanaSundaram, Sinda Zarrouk, Josef Finsterer
Vol 57, No 1 (2023) SARS-CoV-2 neurotropism and other possible causes of olfactory disorders in COVID-19 Abstract
Paweł Sowa, Adam Dadok, Monika Adamczyk-Sowa
Vol 55, No 4 (2021) Screening and diagnosis for mood and anxiety disorders in epilepsy: Polish population reference values Abstract   PDF
Agata M. Grzegorzewska, Wiesław J. Cubała, Mariusz S. Wiglusz
391 - 405 of 520 Items <<   <   22 23 24 25 26 27 28 29 30 31   >   >> 

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl